Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 95.00
-1.00 (-1.04%)
Sep 18, 2026, 1:30 PM CST
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.92 billion as of September 17, 2026. Its market cap has decreased by -31.23% in one year.
Market Cap
2.92B
Enterprise Value
2.39B
Revenue
332.21M
Ranking
n/a
PE Ratio
27.10
Stock Price
95.00
ChartMarket Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.92B, an increase of 97.57%. That is a compound annual growth rate of 24.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.92B | -20.54% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.95B |
| Hi-Clearance | 5.70B |
| WeLeader Biomedical | 3.34B |
| Apex Biotechnology | 3.03B |
| Applied BioCode | 2.85B |
| A Plus Biotechnology | 2.49B |
| Wellell | 2.46B |
| Dynamic Medical Technologies | 2.14B |